Abstract:
Compositions including a combination of a source of choline, a source of magnesium, and a source of L-tryptophan are provided for improving cognitive performance in a subject. The compositions may improve a cognitive impairment and/or brain dysfunction associated with age-related cognitive decline or cognitive decline resulting from a neurodegenerative disease. The compositions may also be effective in improving memory acquisition, memory retention, and recall.
Abstract:
Methods of achieving sustained memory improvements and sustained improvement in learning abilities in an infant are provided. The methods comprise administering an effective amount of sialic acid to an infant or a preterm infant until at least 90 days or three months after birth. The administration results in enhanced brain function, improved learning ability and sustained memory improvement in the infant.
Abstract:
Certain aspects of the methods disclosed herein relate to treating neuroinflammation, preventing neuroinflammation, or reducing neuroinflammation, and combinations of the foregoing in a subject by administration of 2-fucosyl-lactose. Other aspects of the methods disclosed herein relate to treating cognitive impairment, preventing cognitive impairment, or reducing cognitive impairment, and combinations of the foregoing in a subject by administration of 2-fucosyl-lactose.
Abstract:
Disclosed are methods for enhancing learning and/or memory, enhancing memory acquisition, memory retention and recall by inducing a higher long-term potentiation in hippocampal neuronal synapsis in individuals. The methods include administration of 2-fucosyl-lactose to an individual.
Abstract:
Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-lutein. The supplements may enhance central nervous system development in a fetus or breast-feeding newborn infant.
Abstract:
Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
Abstract:
Disclosed are methods for enhancing neural function in an individual, such as an older adult. The methods include administering nutritional compositions comprising HMB to the individual. The nutritional compositions provide benefits for individuals that have or may be at risk of having cognitive decline, cognitive impairment, and neural dysfunction, typically resulting from cognitive diseases associated with neurodegenerative diseases.